Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
康臣葯業治療腎臟疾病藥物於中國獲批開展臨床試驗

2025-04-25T  
康臣葯業委任科學顧問

2025-03-31T  
《業績》康臣葯業全年純利9.1億元人民幣升16.1% 末期息維持0.3港元

2025-03-26T  
康臣葯業SK-08片劑首批受試者成功用藥

2025-03-13T  
康臣葯業財務總監變更

2025-02-24T  
《業績》康臣葯業半年純利4億元人民幣升14.9% 派中期息0.3港元

2024-08-21T  
康臣藥業附屬開發碘普羅胺注射液獲國家藥監局批准

2024-08-07T  
康臣葯業SK-08片獲准開展臨床試驗 碘克沙醇注射液獲頒藥品註冊批件

2024-07-18T  
康臣葯業宣派每股0.3元特別息

2024-05-24T  
《公司業績》康臣葯業全年純利7.85億人幣升14.9% 派末期息30港仙

2024-03-28T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.